Riskpilot← Back to searchSign inGet full accessMEDEX NORGE AS
ASActiveOrg 922168539Kilengaten 18A, 3117 TønsbergRetail sale of sporting equipment · NACE 4763Est. 20192 employees
Revenue 2024
NOK 10,7M
+104% vs 2023
EBITDA margin
10.6%
+195% vs 2023
Equity ratio
44.2%
Financial strength
Net profit 2024
NOK 1,1M
+176% vs 2023
| Revenue | NOK 10,7M | +104% |
| EBITDA | NOK 1,1M | +195% |
| Net profit | NOK 1,1M | +176% |
| Total assets | NOK 2,7M | +19% |
| Equity | NOK 1,2M | +881% |
| Employees | 2 | — |
Legal name
MEDEX NORGE AS
Org number
922168539
Legal form
Aksjeselskap
NACE code
4763 · Retail sale of sporting equipment
Founded
5. februar 2019
Share capital
NOK 109 207
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Erlend henry strømnes
Company purpose
Import, salg og opplæring av produkter innenfor idrett, helse og rehabilitering.
Address
Kilengaten 18A, 3117 Tønsberg
Phone
+4733327000
Email
kundeservice@medex.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 659 | 2 992 | 4 926 | 5 389 | 5 232 | 10 680 |
| Staff expenses | −0 | −123 | −532 | −108 | −585 | −525 |
| EBITDA | 157 | −95 | 64 | 378 | −1 192 | 1 137 |
| Depreciation & amort. | −21 | −23 | −23 | −104 | −161 | −97 |
| EBIT | 136 | −118 | 41 | 273 | −1 353 | 1 040 |
| Net financials | 0 | −3 | −32 | −44 | −80 | −37 |
| Profit before tax | 136 | −122 | 9 | 229 | −1 433 | 1 003 |
| Tax | 30 | −26 | 3 | 50 | −17 | −74 |
| Net profit | 106 | −95 | 6 | 178 | −1 416 | 1 077 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 236 | 874 | 1 866 | 1 921 | 2 272 | 2 714 |
| Equity | 206 | 111 | 116 | 295 | 122 | 1 200 |
| Long-term debt | 0 | 0 | 22 | 778 | 554 | 0 |
| Short-term debt | 30 | 763 | 1 728 | 849 | 1 595 | 1 514 |
| Total debt | 30 | 764 | 1 750 | 1 627 | 2 149 | 1 514 |
EBITDA margin
10.6%
This company
15.8%
Market median
-33% vs market
20192024
Equity ratio
44.2%
This company
38.2%
Market median
+16% vs market
20192024
Return on equity
89.8%
This company
18.4%
Market median
+388% vs market
20192024
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
20192024
Asset turnover
3.94×
This company
1.12×
Market median
+252% vs market
20192024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-17 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.2% | 5.2% | 2024 | |
C. Sørum Invest As | Company | 2.9% | 2.9% | 2024 |
| Individual | 1.8% | 1.8% | 2024 | |
Ytredal Invest As | Company | 1.2% | 1.2% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDEX NORGE AS 
X-BRANDS NORDIC ASBoard members of MEDEX NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thommy Røvik | Chief Executive Officer | 0 companies |
| Christian Sandlie Sørum | Board of Directors | 0 companies |
| Erlend Henry Strømnes | Chairman | 0 companies |
| Kenneth Reistad Røvik | Board of Directors | 0 companies |